Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
247.88B | 263.35B | 271.55B | 232.31B | 232.39B | Gross Profit |
109.36B | 101.60B | 113.30B | 100.75B | 93.72B | EBIT |
6.24B | 11.98B | 27.08B | 31.78B | 27.81B | EBITDA |
16.16B | 27.96B | 36.55B | 38.92B | 36.81B | Net Income Common Stockholders |
20.00M | -26.45B | 18.72B | 22.69B | 17.48B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
60.76B | 44.77B | 47.09B | 66.98B | 50.43B | Total Assets |
292.37B | 297.04B | 349.54B | 305.61B | 271.53B | Total Debt |
45.54B | 54.33B | 42.23B | 41.13B | 39.46B | Net Debt |
1.65B | 19.14B | 3.88B | -12.92B | -4.15B | Total Liabilities |
199.39B | 199.63B | 216.23B | 198.51B | 186.35B | Stockholders Equity |
94.28B | 98.67B | 134.81B | 108.78B | 86.67B |
Cash Flow | Free Cash Flow | |||
42.62B | 3.88B | 24.67B | 34.44B | 23.62B | Operating Cash Flow |
46.26B | 7.18B | 30.86B | 39.06B | 28.93B | Investing Cash Flow |
-15.95B | -8.71B | -34.40B | -19.88B | -15.20B | Financing Cash Flow |
-23.86B | 1.01B | -15.93B | -9.31B | -12.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $236.03B | 26.00 | 20.02% | 2.71% | -5.34% | -30.57% | |
74 Outperform | $67.84B | 44.02 | 189.18% | 1.02% | 7.45% | 46.78% | |
70 Outperform | $18.57B | 7.00 | 12.09% | 3.08% | 10.93% | 43.19% | |
68 Neutral | $24.13B | 12,150.00 | 1.67% | 2.16% | -2.08% | ― | |
68 Neutral | $12.24B | 34.98 | 7.58% | 2.40% | -2.56% | 52.05% | |
64 Neutral | $25.97B | 33.73 | 5.70% | 1.99% | -9.96% | -6.83% | |
60 Neutral | $10.94B | 10.48 | -7.04% | 2.99% | 7.55% | -12.20% |